1. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. Issue 8 (17th December 2007) Authors: Genant, H K; Peterfy, C G; Westhovens, R; Becker, J-C; Aranda, R; Vratsanos, G; Teng, J; Kremer, J M Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 8(2008) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Issue 1 (11th October 2010) Authors: Tak, P P; Rigby, W F; Rubbert-Roth, A; Peterfy, C G; van Vollenhoven, R F; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, T M Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 1(2011) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MRI of the wrist in early rheumatoid arthritis. Issue 5 (13th April 2004) Authors: Peterfy, C G Journal: Annals of the rheumatic diseases Issue: Volume 63:Issue 5(2004) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Issue 2 (3rd April 2008) Authors: Keystone, E; Emery, P; Peterfy, C G; Tak, P P; Cohen, S; Genovese, M C; Dougados, M; Burmester, G R; Greenwald, M; Kvien, T K; Williams, S; Hagerty, D; Cravets, M W; Shaw, T Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 2(2009) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗